Post-Market Surveillance With a Novel mHealth Platform

Description

This is a study to pilot the feasibility of using a novel patient-led, smartphone-based mobile health platform (Hugo) for real-world surveillance of outcomes of patients after sleeve gastrectomy and catheter-base atrial fibrillation ablation.

Study Start Date

January, 26 2018

Estimated Completion Date

August 2018

Interventions

  • Device: A mobile health platform

Study ID

Yale University -- 2000021455

Status

Unknown

Trial ID

NCT03436082

Study Type

Observational [Patient Registry]

Trial Phase

N/A

Enrollment Quota

60

Sponsor

Yale University

Inclusion Criteria

  • Age >18
  • English-speaking
  • Planned for either sleeve gastrectomy or catheter-based atrial fibrillation ablation
  • Participant is willing and able to read and sign consent and participate in study
  • Participant has an email account and a mobile device (smartphone or tablet) able to download the necessary applications
  • Participant is willing to use the mobile health platform and syncable devices (e.g. Fitbit Charge 2)
  • Attending bariatric surgeon or electrophysiologist (as appropriate) concurs that patient is a candidate for enrollment

Exclusion Criteria

    Healthy patients Patients who refuse participation

Gender

All

Ages

18 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (2)

Study Location Distance Name Phone Email
Yale New Haven Hospital - New Haven, Connecticut 18.2 miles None None None
Mayo Clinic - Rochester, Minnesota 997.5 miles Nilay Shah PhD 507-266-5130 shah.nilay@mayo.edu

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.